Analyst Research on Biovail and Elan - Drug Delivery Industry Under Review

www.stockcall.com/ offers investors comprehensive research on the drug delivery industry and has completed analytical research on 

Biovail Corporation

(NYSE: BVF) and 

Elan Corp. plc

(NYSE: ELN). Register with us today at www.stockcall.com/ to have free access to these researches.

Companies in the Drug Delivery industry have recently been posturing for greater market shares which have led to large mergers and acquisitions as companies try to grow. The merging of companies, especially from different countries, is mutually beneficial as the new conglomerate company has access not only to more products but also to established distribution in foreign markets.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the drug delivery industry can have easy and free access to our analyst research and opinions on Biovail Corporation and Elan Corp. plc; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

In news this week is the merger between Biovail Corporation and Valeant Pharmaceuticals International which was completed following a large majority of both companies shareholders approval. Investors looking for free research on Biovail Corporation are welcome to sign up at www.stockcall.com/BVF300910.pdf for our new report.

Companies are also trying to increase sales through research and development. As new drugs are brought to market, successful companies are reaping the benefits. Advancement in the treatment of multiple sclerosis and Alzheimer's disease are at the forefront of some companies' research. These companies are hoping that improvements in the treatments of these diseases will help not only patients, but also profits as well. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the drug delivery industry.

While industry players are focused on bringing successful drugs to market, some have been impacted by illegal sales and marketing procedures. Fines totaling hundreds of millions of dollars have been past down this year alone. Elan Corp. plc for instance had to pay $203 million to the U.S. government in illegal marketing settlement. Investors looking for complimentary research on Elan Corp. plc are welcome to sign up at www.stockcall.com/ELN300910.pdf for our new report.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Person: William T. Knight [e-mail]